Significant movement in price has been observed in Vaishali Pharma Limited. The Exchange, in order to ensure that investors have latest relevant information about the company and to inform the market place so that the interest of the investors is safeguarded, had written to the company. Vaishali Pharma Limited has submitted their response.
VAISHALI · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
The National Stock Exchange wrote to Vaishali Pharma Limited on April 21, 2026, requesting clarification about significant price movement observed in the company's stock. In response dated April 22, 2026, the company stated that there is no undisclosed price-sensitive information and that the price fluctuation is purely market-driven. The company confirmed it has made all necessary disclosures as required under SEBI's Listing Obligations and Disclosure Requirements Regulations, 2015, specifically Regulation 30. The company further stated it has not withheld any material information or event that could affect the price or volume behavior of the stock.
This is a routine clarification filing with no negative implications for shareholders. The company has denied any undisclosed developments, suggesting the price movement was speculative or market-wide rather than company-specific.